GW PHARMA LTD.
66Patents
52Active
66Granted
53Portfolio score
Filing activity: Apr 5, 2001 → Jan 14, 2022 · 12 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7025992B2 | Pharmaceutical formulations | Human Necessities | 87 | Expired |
| US9017737B2 | Use of cannabinoids in combination with an anti-psychotic medicament | Human Necessities | 86 | Active |
| US7622140B2 | Processes and apparatus for extraction of active substances and enriched extracts from natural products | Performing Operations; Transporting | 85 | Expired |
| US7344736B2 | Extraction of pharmaceutically active components from plant materials | Emerging Cross-Sectional Technologies | 84 | Expired |
| US7088914B2 | Device, method and resistive element for vaporizing a medicament | Human Necessities | 79 | Expired |
| US8673368B2 | Cannabinoid-containing plant extracts as neuroprotective agents | Human Necessities | 78 | Active |
| US9125859B2 | Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy | Human Necessities | 70 | Active |
| US9066920B2 | Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy | Human Necessities | 69 | Active |
| US9474726B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 69 | Active |
| US9168278B2 | Use for cannabinoid | Human Necessities | 68 | Active |
| US9956185B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 64 | Active |
| US9956186B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 63 | Active |
| US9956183B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 63 | Active |
| US6946150B2 | Pharmaceutical formulation | Performing Operations; Transporting | 62 | Expired |
| US10111840B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 62 | Active |
| US6730330B2 | Pharmaceutical formulations | Human Necessities | 62 | Expired |
| US9956184B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 62 | Active |
| US9522123B2 | Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy | Human Necessities | 59 | Active |
| US10137095B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 58 | Active |
| US10092525B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 58 | Active |
| US9949937B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 58 | Active |
| US7537005B2 | Dose dispensing system and apparatus | Human Necessities | 53 | Expired |
| US9949936B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 50 | Active |
| US7709536B2 | Pharmaceutical formulation | Performing Operations; Transporting | 45 | Active |
| US9205063B2 | Cannabinoid-containing plant extracts as neuroprotective agents | Human Necessities | 45 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.